Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Bukan solusi tapi beban: Mengapa Prabowonomics justru berisiko terhadap perekonomian rakyat?

(ElKurnia8/Shutterstock)● Presiden Prabowo mengenalkan konsep ‘Prabowonomics’ yang diklaim bisa menumbuhkan ekonomi hingga 8%.● Lain di klaim, ‘Prabowonomics’ justr...

Kenapa nilai zakat Indonesia masih rendah meski pembayaran zakat digital sudah di mana-mana?

● Potensi zakat nasional tembus ratusan triliun.● Dana sebesar itu bisa jadi dana segar pembangunan dan pengentasan kemiskinan nasional.● Pembayaran online ternyata tak mendongkrak p...

‘Lebaran blues’ dan rasa kehilangan: Bagaimana momen hari raya bisa memicu duka

Tampak belakang seorang perempuan mengenakan pakaian salat duduk di kursi roda pada perayaan Idulfitri.Creativa Images/Shutterstock● Bagi mereka yang sedang berduka, hari raya dapat membuat rasa...